Q-Linea
20.80 SEK
-1.89 %
Less than 1K followers
QLINEA
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Q-Linea
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 1.0 | 0.2 | 9.3 | 12.8 | 4.4 | 2.4 | 11.1 |
| growth-% | -75.8 % | 3,741.6 % | 37.0 % | -65.3 % | -46.8 % | 370.3 % | |
| EBITDA | -175.0 | -215.4 | -226.2 | -247.0 | -213.1 | -195.9 | -161.5 |
| EBIT | -179.1 | -221.5 | -233.6 | -262.3 | -230.6 | -213.6 | -176.7 |
| Profit before taxes | -177.4 | -218.7 | -231.2 | -268.7 | -229.4 | -216.9 | -182.5 |
| Net income | -177.4 | -218.7 | -231.2 | -268.7 | -229.4 | -216.9 | -182.5 |
| EPS | -1,022.88 | -1,141.36 | -1,081.82 | -1,215.42 | -459.75 | -245.73 | -27.40 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -17,411.7 % | -88,659.3 % | -2,423.6 % | -1,930.9 % | -4,798.8 % | -8,300.0 % | -1,455.2 % |
| EBIT-% | -17,822.4 % | -91,170.0 % | -2,501.9 % | -2,050.4 % | -5,193.5 % | -9,052.5 % | -1,591.8 % |
| ROE | -52.0 % | -57.5 % | -53.7 % | -164.6 % | -121.0 % | 789.8 % | -54.0 % |
| ROI | -47.4 % | -53.0 % | -49.6 % | -116.9 % | -98.9 % | -146.5 % | -49.4 % |